12:00 AM
 | 
Jan 22, 2001
 |  BioCentury  |  Finance

Analyst picks & changes

Immunex Corp. (IMNX), Seattle, Wash.

Business: Biopharmaceuticals

Banc of America analyst Eric Ende lowered his price target to $61 from $65, reduced his 2001 EPS...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >